We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
+1.03%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$207M
AUM Growth
+$29.2M
Cap. Flow
+$27.6M
Cap. Flow %
13.39%
Top 10 Hldgs %
88.47%
Holding
181
New
37
Increased
23
Reduced
71
Closed
16

Sector Composition

Rank Sector Weight
1 Real Estate 17.29%
2 Healthcare 5.02%
3 Technology 2.17%
4 Industrials 1.56%
5 Financials 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IGSB icon
76
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
$78K 0.04%
1,424
-25
-2% -$1.37K
LQD icon
77
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$35.2B
$78K 0.04%
579
-18
-3% -$2.45K
SCHP icon
78
Schwab US TIPS ETF
SCHP
$16.5B
$78K 0.04%
2,534
-120
-5% -$3.67K
WIP icon
79
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$492M
$77K 0.04%
+1,414
New +$77.2K
IMVT icon
80
Immunovant
IMVT
$8.27B
$76K 0.04%
2,150
+1,500
+231% +$45.1K
QURE icon
81
uniQure
QURE
$2.77B
$74K 0.04%
2,000
+1,425
+248% +$58.4K
EXEL icon
82
Exelixis
EXEL
$14.1B
$73K 0.04%
3,000
-100
-3% -$2.33K
HSY icon
83
Hershey
HSY
$34.8B
$73K 0.04%
510
-38
-7% -$5.39K
EXR icon
84
Extra Space Storage
EXR
$31.3B
$72K 0.03%
673
-47
-7% -$4.86K
MAA icon
85
Mid-America Apartment Communities
MAA
$15.5B
$71K 0.03%
611
-43
-7% -$4.96K
TBIO
86
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$69K 0.03%
+5,100
New +$78.6K
ODT
87
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$68K 0.03%
5,100
+4,525
+787% +$128K
ALXN
88
DELISTED
Alexion Pharmaceuticals
ALXN
$68K 0.03%
590
-135
-19% -$14.6K
REGN icon
89
Regeneron Pharmaceuticals
REGN
$70.9B
$67K 0.03%
+120
New +$72.8K
AMZN icon
90
Amazon
AMZN
$2.66T
$63K 0.03%
400
-60
-13% -$9.46K
ZGNX
91
DELISTED
Zogenix, Inc.
ZGNX
$63K 0.03%
3,500
+750
+27% +$18.4K
CHTR icon
92
Charter Communications
CHTR
$16.2B
$62K 0.03%
99
-9
-8% -$5.31K
KNSA icon
93
Kiniksa Pharmaceuticals
KNSA
$4.92B
$61K 0.03%
+4,000
New +$75.1K
AUPH icon
94
Aurinia Pharmaceuticals
AUPH
$2.05B
$60K 0.03%
+4,100
New +$59.4K
DG icon
95
Dollar General
DG
$27.7B
$57K 0.03%
274
-25
-8% -$4.92K
COST icon
96
Costco
COST
$417B
$56K 0.03%
158
-15
-9% -$5.04K
CLX icon
97
Clorox
CLX
$11.6B
$54K 0.03%
257
-22
-8% -$4.9K
ALLO icon
98
Allogene Therapeutics
ALLO
$618M
$53K 0.03%
+1,400
New +$52.8K
CINF icon
99
Cincinnati Financial
CINF
$28B
$53K 0.03%
677
-47
-6% -$3.64K
MRSN
100
DELISTED
Mersana Therapeutics
MRSN
$53K 0.03%
+114
New +$57.6K

Similar funds

AlphaCentric Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, AlphaCentric Advisors held 181 positions worth $207M, up 16% from $177M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

AlphaCentric Advisors deployed $27.6M of net new capital in Q3 2020, opening 37 new positions and adding to 23 existing holdings. Its largest new stake was iShares JPMorgan EM High Yield Bond ETF: 6,992 shares worth $305K.

By sector, the portfolio is most concentrated in Real Estate at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was iShares 1-3 Year Treasury Bond ETF, an estimated $2.55M trimmed.

  • AlphaCentric Advisors's largest Q3 2020 buy was iShares JPMorgan EM High Yield Bond ETF: 6,992 shares worth $305K.
  • AlphaCentric Advisors added most to iShares MBS ETF in Q3 2020, an estimated $27.6M increase.
  • AlphaCentric Advisors's biggest Q3 2020 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $2.55M.
  • AlphaCentric Advisors fully exited Nano Dimension in Q3 2020, selling an estimated $330K.
  • AlphaCentric Advisors's ten largest holdings make up 88% of its $207M portfolio in Q3 2020.
  • AlphaCentric Advisors opened 37 new positions and closed 16 in Q3 2020.
  • AlphaCentric Advisors's portfolio value rose 16% quarter-over-quarter to $207M.

Based on AlphaCentric Advisors's 13F filing for Q3 2020, filed 11 Mar 2022.